What This Document Is
This is a detailed study guide designed to help students prepare for Exam 4 in NURS 663: Psychiatric Nursing at Maryville University. It focuses on substance use disorders and related pharmacological interventions. The guide consolidates key information needed for exam success, offering a focused review of essential concepts and medications.
Why This Document Matters
This study guide is crucial for psychiatric nursing students approaching their fourth exam. It’s particularly valuable for those needing a concise yet comprehensive overview of substance use disorder classifications, terminology, and the specifics of medications used in treatment. It serves as a targeted review tool to reinforce learning from course materials and prepare for assessment. This resource is best used *after* engaging with lectures, readings, and other course content.
Common Limitations or Challenges
This study guide is a review tool, not a substitute for comprehensive course study. It provides a framework for understanding the material but does not offer in-depth explanations of underlying psychiatric principles or clinical reasoning. It is not a clinical practice guideline and should not be used for direct patient care decisions.
What This Document Provides
The full study guide includes: distinctions between mild, moderate, and severe substance use disorders based on symptom criteria; definitions of key terms like abuse, cross-tolerance, detoxification, misuse, tolerance, and withdrawal; a detailed breakdown of several medications—Acamprosate, Buprenorphine, Bupropion, Chlordiazepoxide, Clonidine, Disulfiram, Flumazenil, and Lorazepam—covering their mechanisms of action, major side effects, and essential patient education points.
This preview *does not* include detailed dosage calculations, comprehensive side effect profiles, or clinical case studies. It also does not provide the full spectrum of medications covered in the exam.
